Cargando…

Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease

Pre-clinical studies have supported the use of mesenchymal stem cells (MSC) to treat highly prevalent neurodegenerative diseases such as Parkinson’s disease (PD) but preliminary trials have reported controversial results. In a rat model of PD induced by MPTP neurotoxin, we first observed a significa...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Marcia C. L., Secco, Mariane, Suzuki, Daniela E., Janjoppi, Luciana, Rodini, Carolina O., Torres, Layla B., Araújo, Bruno H. S., Cavalheiro, Esper A., Zatz, Mayana, Okamoto, Oswaldo Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Humana Press Inc 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252034/
https://www.ncbi.nlm.nih.gov/pubmed/21503590
http://dx.doi.org/10.1007/s12015-011-9256-4
_version_ 1782220596169408512
author Pereira, Marcia C. L.
Secco, Mariane
Suzuki, Daniela E.
Janjoppi, Luciana
Rodini, Carolina O.
Torres, Layla B.
Araújo, Bruno H. S.
Cavalheiro, Esper A.
Zatz, Mayana
Okamoto, Oswaldo Keith
author_facet Pereira, Marcia C. L.
Secco, Mariane
Suzuki, Daniela E.
Janjoppi, Luciana
Rodini, Carolina O.
Torres, Layla B.
Araújo, Bruno H. S.
Cavalheiro, Esper A.
Zatz, Mayana
Okamoto, Oswaldo Keith
author_sort Pereira, Marcia C. L.
collection PubMed
description Pre-clinical studies have supported the use of mesenchymal stem cells (MSC) to treat highly prevalent neurodegenerative diseases such as Parkinson’s disease (PD) but preliminary trials have reported controversial results. In a rat model of PD induced by MPTP neurotoxin, we first observed a significant bilateral preservation of dopaminergic neurons in the substantia nigra and prevention of motor deficits typically observed in PD such as hypokinesia, catalepsy, and bradykinesia, following intracerebral administration of human umbilical cord-derived MSC (UC-MSC) early after MPTP injury. However, surprisingly, administration of fibroblasts, mesenchymal cells without stem cell properties, as a xenotransplantation control was highly detrimental, causing significant neurodegeneration and motor dysfunction independently of MPTP. This observation prompted us to further investigate the consequences of transplanting a MSC preparation contaminated with fibroblasts, a plausible circumstance in cell therapy since both cell types display similar immunophenotype and can be manipulated in vitro under the same conditions. Here we show for the first time, using the same experimental model and protocol, that transplantation of UC-MSC induced potent neuroprotection in the brain resulting in clinical benefit. However, co-transplantation of UC-MSC with fibroblasts reverted therapeutic efficacy and caused opposite damaging effects, significantly exacerbating neurodegeneration and motor deficits in MPTP-exposed rats. Besides providing a rationale for testing UC-MSC transplantation in early phases of PD aiming at delaying disease progression, our pre-clinical study suggests that fibroblasts may be common cell contaminants affecting purity of MSC preparations and clinical outcome in stem cell therapy protocols, which might also explain discrepant clinical results. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12015-011-9256-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-3252034
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Humana Press Inc
record_format MEDLINE/PubMed
spelling pubmed-32520342012-01-11 Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease Pereira, Marcia C. L. Secco, Mariane Suzuki, Daniela E. Janjoppi, Luciana Rodini, Carolina O. Torres, Layla B. Araújo, Bruno H. S. Cavalheiro, Esper A. Zatz, Mayana Okamoto, Oswaldo Keith Stem Cell Rev Article Pre-clinical studies have supported the use of mesenchymal stem cells (MSC) to treat highly prevalent neurodegenerative diseases such as Parkinson’s disease (PD) but preliminary trials have reported controversial results. In a rat model of PD induced by MPTP neurotoxin, we first observed a significant bilateral preservation of dopaminergic neurons in the substantia nigra and prevention of motor deficits typically observed in PD such as hypokinesia, catalepsy, and bradykinesia, following intracerebral administration of human umbilical cord-derived MSC (UC-MSC) early after MPTP injury. However, surprisingly, administration of fibroblasts, mesenchymal cells without stem cell properties, as a xenotransplantation control was highly detrimental, causing significant neurodegeneration and motor dysfunction independently of MPTP. This observation prompted us to further investigate the consequences of transplanting a MSC preparation contaminated with fibroblasts, a plausible circumstance in cell therapy since both cell types display similar immunophenotype and can be manipulated in vitro under the same conditions. Here we show for the first time, using the same experimental model and protocol, that transplantation of UC-MSC induced potent neuroprotection in the brain resulting in clinical benefit. However, co-transplantation of UC-MSC with fibroblasts reverted therapeutic efficacy and caused opposite damaging effects, significantly exacerbating neurodegeneration and motor deficits in MPTP-exposed rats. Besides providing a rationale for testing UC-MSC transplantation in early phases of PD aiming at delaying disease progression, our pre-clinical study suggests that fibroblasts may be common cell contaminants affecting purity of MSC preparations and clinical outcome in stem cell therapy protocols, which might also explain discrepant clinical results. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12015-011-9256-4) contains supplementary material, which is available to authorized users. Humana Press Inc 2011-04-19 2011 /pmc/articles/PMC3252034/ /pubmed/21503590 http://dx.doi.org/10.1007/s12015-011-9256-4 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Pereira, Marcia C. L.
Secco, Mariane
Suzuki, Daniela E.
Janjoppi, Luciana
Rodini, Carolina O.
Torres, Layla B.
Araújo, Bruno H. S.
Cavalheiro, Esper A.
Zatz, Mayana
Okamoto, Oswaldo Keith
Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease
title Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease
title_full Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease
title_fullStr Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease
title_full_unstemmed Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease
title_short Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease
title_sort contamination of mesenchymal stem-cells with fibroblasts accelerates neurodegeneration in an experimental model of parkinson’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252034/
https://www.ncbi.nlm.nih.gov/pubmed/21503590
http://dx.doi.org/10.1007/s12015-011-9256-4
work_keys_str_mv AT pereiramarciacl contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease
AT seccomariane contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease
AT suzukidanielae contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease
AT janjoppiluciana contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease
AT rodinicarolinao contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease
AT torreslaylab contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease
AT araujobrunohs contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease
AT cavalheiroespera contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease
AT zatzmayana contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease
AT okamotooswaldokeith contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease